The patterning of the mesoderm of the sea urchin embryo is a classical paradigm of epithelial mesenchymal interactions in organogenesis, yet little is known of its molecular basis. Here we address the role of the homeobox gene, SpMsx, a member of the highly conserved Msx gene family, in this process. Msx genes have been shown to function in the dorsoventral patterning of the central nervous system in Drosophila and in a variety epithelial-mesenchymal interactions in vertebrates. We showed previously that the SpMsx gene is expressed during embryogenesis in a complex and dynamic pattern consistent with roles in the development of subpopulations of endoderm, mesoderm, and oral ectoderm. To perturb this pattern of expression and thus probe the function of SpMsx, we injected SpMsx mRNA into single-cell zygotes and monitored development morphologically and with a series of territory-specific molecular markers. RT-PCR analysis revealed that injected SpMsx transcripts persisted at least until the gastrula stage in amounts comparable to endogenous levels. Injected embryos exhibited deficiencies in the organization of primary and secondary mesenchyme cells within the blastocoelic cavity, as well as abnormalities in spicule number and shape. Defects in the endoderm were also common, including reduced or absent archenterons. Micromere transplantation experiments revealed that the defects in skeletogenic mesenchyme patterning were non-cell autonomous, consistent with findings that cell-cell interactions between ectoderm and the progenitors of the skeletogenic mesenchyme, the primary mesenchyme cells (PMCs), are important both for PMC guidance and spicule morphogenesis. Our data, taken together with observations in other organisms on the role of Msx genes in embryonic signaling processes, particularly involving the BMP pathway, suggest that SpMsx may be a part of the mechanism by which the ectoderm influences both the arrangement of primary mesenchyme cells within the blastocoel and the shapes of the skeletal rods. FIG. 6. Test of the locus of the mesenchyme patterning defect by micromere transplantation. (A) Schematized strategy of micromere transplantation experiment. Zygotes were injected with SpMsx or control SpMsx fs mRNA and reared to the 16-cell stage. Micromeres were removed from SpMsx-injected and control-injected 16-cell embryos and transplanted into uninjected embryos from which micromeres were removed. At the same time, micromeres were transplanted from uninjected embryos into SpMsx-injected or control-injected embryos. In some experiments, micromeres were labeled with the fluorescent dye RITC prior to transplantation. Chimeric and control embryos were reared to the 20-blastula stage (B) or the 72-h pluteus stage (C) and examined by microscopy. Representative examples of some of the chimeras are shown in B and C. The composition of the chimeras is shown in the schematics in the left panels. Images of chimeras at the 20-h blastula stage are shown in B. The upper left image is a brightfield view; the others are epifluorescence images of the progeny of RITC-labeled micromeres (PMCs). The upper right image is a chimera composed of control-injected mesomeres ϩ macromeres with four uninjected micromeres. Note that the PMCs are arranged normally in a subequatorial ring. The two lower images show examples of the chimera containing micromeres from a control-injected embryo and mesomeres ϩ macromeres from an SpMsx-injected embryo. Note that the PMCs are arranged irregularly. (C) DIC images of chimeras at the 60-h prism stage. Note that the chimera containing uninjected mesomeres ϩ macromeres and SpMsx-injected micromeres (top) is morphologically normal. In contrast, the chimera containing SpMsx-injected mesomeres ϩ macromeres and uninjected micromeres (bottom) has supernumerary spicules. At least four are visible as pinkish lines or foci. Moreover, the two largest spicules have clearly abnormal morphologies.
INTRODUCTION
Metazoan organogenesis is characterized by interactions between dissimilar tissues that mutually influence cell fate and pattern. Later events in the regionalization of sea urchin embryo, particularly the patterning of the larval skeleton, serve as a paradigm for such interactions (Gustafson and Wolpert, 1967; Ettensohn et al., 1997) . By the early blastula stage the sea urchin embryo consists of five territories, the oral and aboral ectoderm, vegetal plate, skeletogenic mesenchyme, and small micromeres (Davidson, 1989; Cameron and Davidson, 1991) . These territories are specified in part by the differential inheritance of maternal cytoplasmic determinants, but are also highly influenced by inductive interactions (Wilt, 1987; Davidson, 1989) . Under the current model of sea urchin embryogenesis, the large micromeres, which are themselves specified autonomously in early cleavage, act as a key signaling center, entraining a series of signaling events that specify the vegetal plate and overlying tiers of blastomeres (Horstadius, 1939; Wilt, 1987; Davidson, 1989; Davidson, 1993, 1995) . Oral and aboral ectoderm are thought to be specified in part by maternal determinants and in part through interactions with vegetal blastomeres and with each other (Wikramanayake et al., 1995) . The skeletogenic mesenchyme founder cells give rise to one of the two mesodermal cell types in the early sea urchin embryo (Wilt, 1987) . The other mesodermal cell type, the secondary mesenchyme cells (SMCs), become specified around the blastula stage as a subdivision of the original endomesoderm territory. The SMC domain in the center of the vegetal plate is fated to produce pigment cells, blastocoelar cells, and circumesophageal muscle cells, although it can also give rise to skeletogenic mesenchyme in embryos from which primary mesenchyme cells have been removed (Ruffins and Ettensohn, 1996; Ettensohn, 1992; Ettensohn and McClay, 1988) .
Despite the early determination of the primary mesenchyme, cell-cell interactions have a profound influence on its patterning . At the mesenchyme blastula stage, primary mesenchyme cells (PMCs) ingress into the blastocoel and, after a brief wandering phase, become distributed in a circular pattern on the subequatorial blastocoel wall. The PMC arrays form two ventrolateral clusters, which serve as initiation sites for the growth of the triradiate spicules. PMCs will form spicules when cultured in isolation (Okazaki, 1975) . However, transplantation experiments show that the prospective ectoderm provides cues that are important for initial PMC placement as well as for later growth and morphogenesis of the spicules (Ettensohn, 1990; Hardin et al., 1992; Armstrong et al., 1993; Ettensohn et al., 1997) .
Msx genes have emerged as candidates for regulating epithelial mesenchymal interactions, such as those that direct skeletogenesis (Davidson, 1995) . Msx genes are a phylogenetically widespread gene family characterized by a distinct and highly conserved homeodomain. Loss of function mutations in the Drosophila Msx-related gene, msh, lead to dorsoventral patterning defects in neurogenesis (Isshiki et al., 1997) . Homologous targeting in mice has shown that Msx genes have pleiotropic roles in organogenesis, functioning in the epithelial mesenchymal interactions that underlie the development of the neural tube, brain, skull, teeth, eyes, skin, mammary glands, and kidneys (Satokata and Maas, 1994; R. Maas, personal communication) . Intriguingly, overexpression of murine Msx2, one of three Msx genes present in mammals, produces defects similar to those observed in knockout mice (Liu et al., 1995; Winograd et al., 1997; Y.-H. Liu and R. Maxson, unpublished observations) . Thus the developmental processes involving Msx genes are sensitive to both increases and decreases in Msx gene dosage, consistent with a role for these genes in signaling. It has become increasingly clear that Msx genes function in the BMP pathway (Vainio et al., 1993) . The murine Msx1 gene is required for BMP4 autoinduction in the oral mesenchyme (Chen et al., 1996) . In the mouse mesenchymal cell line C14, upregulation of Msx2 is FIG. 1. Schematic maps of Msx expression constructs. Full-length cDNAs encoding the murine Msx2 or sea urchin (S. pururatus) SpMsx sequences were fused with an SV40 trailer and polyadenylation signal and cloned into an expression vector containing a T7 promoter. As a control, a frameshift mutation was introduced into the Msx2 coding sequence, resulting in a termination codon at amino acid position 129, 12 amino acids N-terminal to the homeodomain. an immediate early response to BMP4 treatment (K. Lyons and R. Maxson, unpublished), and in Xenopus, Msx1 can rescue embryos expressing a dominant negative BMP receptor (Suzuki et al., 1997) . Moreover, epistasis studies have shown that expression of the Drosophila msh during neurogenesis is regulated by Dpp (D' Alessio and Frasch, 1996) .
The well-documented role of Msx genes in vertebrate organogenesis together with the conservation of Msx gene regulation by BMPs suggested to us that an analysis of SpMsx expression and function would illuminate signaling processes that underlie differentiation and patterning within the sea urchin embryonic territories. We showed previously that SpMsx transcripts are distributed generally in blastula stage embryos and become restricted to the prospective oral ectoderm and vegetal plate by the late blastula stage (Dobias et al., 1997) . Subsequently, SpMsx is expressed in the archenteron, in SMCs, and in subregions of the oral ectoderm, including the growing larval arms.
Here, as a first test of whether SpMsx functions in tissue interactions in the sea urchin zygote, we used RNA injection to alter its expression temporally and spatially. We show that overexpression of SpMsx produced a set of phenotypes beginning at the late blastula stage when the endogenous SpMsx gene is activated. SpMsx-injected embryos exhibited impaired development of the archenteron. In addition, there were defects in the patterning of the primary and secondary mesenchyme, as well as in spicule morphogenesis. Micromere transplantation experiments showed that the primary mesenchyme defects were conditional on interactions with the prospective ectoderm, demonstrating that overexpression/misexpression of SpMsx perturbs signaling processes that pattern the mesenchyme. Varying amounts (10 3 -10 6 molecules) of SpMsx mRNA produced by transcription with T7 RNA polymerase were reverse transcribed and subjected to 23 cycles of PCR in the presence of [ 32 P]dCTP. The upstream PCR primer was located in the SpMsx protein coding sequence and the downstream primer in the SV40 trailer; thus the PCR product was specific for the injected mRNA. The PCR products were size separated on an acrylamide gel and the 320-nt SpMsx band was visualized and quantitated with a phosphoimager. A plot of the radioactivity in the SpMsx PCR product versus the input number of SpMsx mRNA molecules is shown below an image of the SpMsx band on the gel. The smaller graph is an enlargement of the initial part of the larger graph (B) Stability of synthetic SpMsx mRNA after injection into embryos. In vitro transcribed SpMsx mRNA (3 ϫ 10 5 molecules) was injected into fertilized S. purpuratus eggs. RNA was extracted immediately after injection, at 4, 20, and 48 h postfertilization. This RNA (1.9 embryo equivalents or approximately 5.7 ng) was subjected to RT-PCR at the same time and using the same procedure as the standard reaction shown in (A). Shown are an image of the radiolabeled SpMsx PCR product on a gel and a plot of the estimated number of injected SpMsx mRNA molecules as a function of time after fertilization. For reference, this plot also shows the estimated number of endogenous SpMsx transcripts calculated from the RNAse protection data of Dobias et al. (1997) . Below are diagrams of embryos with the expression pattern of the endogenous SpMsx gene indicated by shading.
MATERIALS AND METHODS

Construction
FIG. 3.
Arrangement of mesenchyme cells in SpMsx-injected embryos. Synthetic SpMsx mRNA or frameshift control mRNA ( Fig. 1) were injected into fertilized S. purpuratus eggs. These eggs were reared to the mesenchyme blastula stage and examined by differential interference contrast (DIC) microscopy. DIC images are shown on the left; corresponding camera lucida drawings illustrating the locations of the mesenchyme cells are on the right. A and B show a typical control-injected embryo. Note the ingressed mesenchyme cells arrayed in a circular pattern in the vegetal hemisphere below the equator. (Approximately 3/4 of the circle is visible in the plane of focus.) In contrast, in SpMsx-injected embryos (C-H), PMCs are less regularly arranged.
using primer 1 (tctacttcgaggacatct) and primer 2 (aggtcggatttctgatgaaccagatgaagggcttaattttgtcgcc). Exon II of the SpMsx gene was PCR amplified by using primer 3 (caaaattaagcccttcatctggttcatcagaaatccgacct) and primer 4 (gcaatgtccaatgtcttgg). The PCR conditions were as follows: denaturation was at 95°C for 2 min; 95°C, 1 min; 45°C, 2 min; 72°C, 3 min; 30 cycles, 72°C 10 min. Exon I and exon II PCR products were annealed at the overlapping region at 94°C, 3 min; 55°C, 40 s; 37°C, 5 min. A second-round PCR was performed with primer 1 and 4 using the same PCR conditions. The final PCR product was cloned at the EcoRI site of the PCR II vector (Invitrogen) and then subcloned into the EcoRI site of the pskCmvSv-40 vector (Liu et al., 1995) . The amino acid sequence encoded by the PCR product was identical to that of the Msx2 gene. The pskCmvSv-40 vector was created by excising a fragment of immediate early promoter of the human cytomegalovirus (CMV) from pRc/CMV (Invitrogen) as a SalI/HindIII fragment and ligating to compatible sites on pBluescript 1 (Stratagene). A 2.1-kb BamHI/ BglII fragment from pKSV10 (Pharmacia) was also inserted to supply a polyadenylation signal (Liu et al., 1995) . The pCMVMsx2 was created by inserting a 1.0-kb fragment of the mouse Msx2 cDNA into the HindIII/EcoRI site. pCMVMsx2FS (frame shift) (Liu et al., 1995) was generated by linearizing the pCMVMsx2WT at the junction between the two exons with NdeI and by filling in with the Klenow enzyme ( Fig. 1) .
Preparation of synthetic mRNAs for microinjection. To generate DNA templates for in vitro RNA synthesis, pCMVSpMsx, pCMVMsx2WT, and pCMVMsx2FS plasmids were digested with XbaI and SalI (Boehringer-Mannheim Biochemicals) and transcribed with T7 polymerase. The SpOct cDNA plasmid was linearized with HindIII (Boehringer-Mannheim Biochemicals) and transcribed with T3 polymerase. The 5Ј capped full-length mRNAs were synthesized using the Message Machine kit (Ambion, Inc.). All mRNAs synthesized were checked for integrity on a denaturing formaldehyde agarose gel before microinjection. SpMsx mRNA was injected at a concentration of 0.2 g/ul; mouse Msx2 and Msx2 frameshift mRNAs were microinjected at 0.8 g/ul in 20% sterile glycerol.
Zygote collection and microinjection. Sea urchin Strongylocentrotus purpuratus (Marinus, CA) gametes were collected after injecting 0.5 M KCl into the perivisceral coelom. Eggs were treated in pH 4.5-5.0 acid sea water for 2 min, washed twice in filtered sea water (FSW), and then attached to protamine sulfate-coated petri dishes. The eggs were fertilized by adding sperm diluted in FSW immediately before microinjection. Microinjections were performed as described (Bell et al., 1992) using a Leitz Labovert FS microscope equipped with a flow microsyringe. Zygotes (50 -100) were injected per dish with in vitro transcribed mRNAs. Control mRNAs were injected into the same batch of eggs. Injected embryos were incubated at 15°C in a humidified chamber. Only embryos that developed normally through 4 h postfertilization were used in the analysis. Those damaged during the injection process were discarded. Noninjected, fertilized embryos were also followed over the course of each experiment as a control. Embryos were photographed under a Nikon Diaphot microscope using either phase or differential interference contrast (DIC) optics and Kodak Royal 25 film.
RT-PCR analysis. Total embryo RNA was collected at 15 min, 3 h, 24 h, and 48 h after microinjection of SpMsx mRNA by extraction with RNAzol B (Tel-Test, Inc.) according a protocol supplied by the manufacturer. An amount of RNA equivalent to 1.9 embryos was used for each analysis. First-strand cDNA was synthesized using the Superscript Preamplification System for First-Strand cDNA Synthesis (Gibco, BRL) and random hexamers (20 ng/1 g RNA). In vitro transcribed SpMsx mRNA (0.4 g) was reverse transcribed to first-strand cDNA in order to provide a standard curve for measuring the amount of mRNA injected. cDNA was amplified by PCR with Taq polymerase in a 25-l reaction including 2.5 l 10ϫ PCR buffer, 1.5 l of 25 mM MgCl 2 , 0.5 l 10 mM dNTP mix, [ 32 P]dCTP 0.1 l (1 Ci), 100 ng of each primer, Taq polymerase, 2.5 units, and cDNA equivalent to 1.9 embryos. Primers were designed to hybridize with the portion of the SpMsx 3Ј UTR derived from SV40. The primers were ggactttccttcagaattgc, designated SV40-5Ј, and ggatctctagtcaaggcact, designated SV40-3Ј. PCR conditions were as follows: 95°C, 2 min; 94°C, 1 min; 55°C, 1 min; 72°C, 1 min. PCR was carried out for 23 cycles. The PCR products were electrophoresed on a 6% native polyacrylamide gel and exposed to Kodak XAR-5 x-ray film (Eastman Kodak) for 30 min. Quantitation was performed using a phosphoimager volume report (Molecular Dynamics).
Detection of territory-specific markers. Indirect immunofluorescence was carried out essentially as described (Ettensohn and McClay, 1988; Wikramanayake et al., 1995) . Embryos were fixed with 2% paraformaldehyde (Electron Microscopy Sciences) in filtered sea water for 1-2 h, washed with filtered sea water, and stained with Ecto V (Coffman and McClay, 1990) or Spec I (Tomlinson and Klein, 1990) antibodies. The Ecto V monoclonal antibody was kindly provided by Dr. D. McClay (Duke) and the Spec I polyclonal antibody by Dr. W. Klein (M. D. Anderson). Embryos were fixed with methanol at Ϫ20°C for 20 min, washed with sea water, and stained with Endo I antibody (Wessel and McClay, 1987) (kindly provided by Dr. G. Wessel (Brown)). Embryos were stored in sea water with 0.01% sodium azide.
For Ecto V staining, fixed embryos were extracted with acetone (Ϫ20°C) for 10 min and then washed with acetone-sea water (1:1) and sea water. Embryos were incubated with Ecto V antibody at room temperature for 1 h; washed three times with sea water, 10 min each; blocked with 10% normal goat serum for 15 min; washed twice with sea water; incubated with goat anti-mouse antibody conjugated with rhodamine (1:40) (Boehringer-Mannheim Biochemicals) for 1 h, and washed three times with sea water.
Spec I antibody was preabsorbed with 10-h sea urchin embryo acetone powder. Fixed embryos were treated with 1% Triton X-100 overnight and blocked with 3 mg/ml BSA, 0.2% Tween 20 in PBS for 30 min. Embryos were incubated in Spec I mixed with blocking buffer at 1:500 dilution for at least 3 h and washed three times with blocking buffer for at least 10 min each. Embryos were then incubated in goat anti-rabbit antibody conjugated with rhodamine (Boehringer-Mannheim Biochemicals) (1:40) for 1 h and washed three times with blocking buffer for at least 10 min each.
For Endo I staining, embryos were incubated with Endo I antibody in a 1:50 dilution for 20 min, washed with sea water, incubated with goat anti-mouse secondary antibody conjugated with rhodamine (1:40) (Boehringer-Mannheim Biochemicals) for 20 min, and washed 3ϫ with sea water. After staining, embryos were covered with a supported coverslip and photographed under a Zeiss epifluorescence microscope (31ϫ magnification) with Kodak Ektachrome 320 tungsten film.
Micromere transplantations. Zygotes were injected with SpMsx as described above. At the second cleavage stage, noninjected control embryos were transferred into sea water containing rhodamine B isothiocyanate (RITC) at 0.4 g/ml for 30 min and then washed twice in filtered sea water (Ettensohn, 1990) . At the fourth cleavage, micromeres from injected and noninjected sets were microsurgically removed using glass needles (Ransick and Davidson, 1995) . Intact sets of four micromeres were then transplanted onto the vegetal ends of the embryos of the respective opposite group to produce the following two types of chimeric combinations: (i) nonfluorescent SpMsx-injected macromeres and mesomeres, plus RITC-labeled uninjected micromeres; and (ii) RITC-labeled, noninjected macromeres and mesomeres, plus nonfluorescent SpMsx-injected micromeres. Successful transplants were transferred to agar tunnels (Ransick and Davidson, 1995 . For observation, embryos were placed on a slide, covered with a supported coverslip, and photographed under a Nikon Diaphot phase microscope (40ϫ amplification) using Kodak Royal 25 film. The fluorescent images were recorded under a Zeiss epifluorescence microscope (31ϫ Amplification) using Kodak Ektachrome 320 tungsten film.
RESULTS
The Injection of SpMsx mRNA into S. purpuratus Zygotes Causes Defects in the Archenteron and in the Patterning of the Primary and Secondary Mesenchyme
A simple strategy for the misexpression of a potential developmental regulatory gene in sea urchin embryos is the injection of mRNA (Cameron et al., 1994; Char et al., 1994) . Unlike injected DNA, which is incorporated into blastomere genomes in a mosaic fashion, injected RNA is uniformly distributed and is presumably translated in all embryonic cells (Cameron et al., 1994) .
We used both sea urchin and murine Msx constructs as reagents to test the effect of increasing Msx gene dosage on embryogenesis (Dobias et al., 1997; Liu et al., 1995) . Initial studies were performed with the murine Msx2 gene; subsequent, more detailed analyses were carried out with the SpMsx gene of S. purpuratus (Fig. 1) . The murine Msx2 and SpMsx constructs included full-length protein coding sequences fused with a trailer and poly(A) addition site from SV40 (Liu et al., 1995;  Fig. 1 ). These Msx-SV40 fusions were cloned into an expression vector and sense RNAs were generated by transcription with T7 polymerase. As a control for any toxic effects of RNA, we used mRNA derived from a frameshift mutant of the murine Msx2 gene that resulted in a termination codon at amino acid position 129, 12 amino acids N-terminal to the homeodomain. A control for the specificity of any developmental consequences of SpMsx injection was provided by mRNA encoding SpOct, a POU-class transcription factor expressed early in sea urchin embryogenesis (Char et al., 1993) . We showed previously that injection of SpOct mRNA had no discernible effect on development (Char et al., 1994) .
In initial tests of RNA toxicity, we established that injection of 1-2 pl of control murine Msx2 frameshift mRNA, or SpOct mRNA, at concentrations up to 1 mg/ml (approximately 2 ϫ 10 6 molecules), did not cause any morphological defects in embryogenesis at least through the 72-h pluteus stage (data not shown). Higher concentrations caused defects during cleavage stages. In most experiments we injected approximately 3 ϫ 10 5 molecules of Msx mRNA, substantially below the toxicity level.
We showed previously that endogenous SpMsx transcripts are first detectable in S. purpuratus embryos between 16 and 18 h after fertilization (Dobias et al., 1997) . The SpMsx transcript level peaks at 25 h at 8 ϫ 10 4 transcripts and then declines approximately 10-fold by the pluteus stage (Dobias et al., 1997; S. Dobias and R. Maxson, unpublished observations; summarized in Fig. 2B ). Given this pattern, we expected that the injection of Msx mRNA into fertilized eggs would lead to premature Msx gene expression in early embryos. Also, depending on the stability of the injected Msx transcripts and the resultant protein, injected Msx mRNA might also result in overexpression and ectopic expression of Msx protein at the blastula stage or later. It was not possible to measure Msx protein levels due to the lack of an anti-Msx antibody. However, we were able to test the stability of SpMsx mRNA during development. For this purpose, we injected SpMsx mRNA (3 ϫ 10 5 molecules) into single cell zygotes. Then, at various times after injection from 0 to 48 h, we prepared whole-embryo RNA and analyzed it for SpMsx mRNA by semiquantitative RT-PCR. First, a titration with SpMsx mRNA was carried out to establish the relationship between the RT-PCR signal and the number of SpMsx RNA molecules remaining in embryos after injection. As can be seen in Fig. 2A , at 23 cycles of PCR, a plot of the radioactivity in the PCR product versus the number of SpMsx molecules was linear in the range 10 3 -10 6 molecules. RT-PCR, performed together with the control titration shown in Fig. 2A , revealed that a substantial amount of the injected RNA decayed during embryogenesis (Fig. 2B) . By the 20-h blastula stage, approxi-mately 9 ϫ 10 4 molecules of the injected SpMsx mRNA remained, similar in amount to the peak level of endogenous SpMsx transcripts. By 48 h, 5 ϫ 10 4 molecules of injected SpMsx mRNA were present. This was approximately fourfold above endogenous levels. These data demonstrate, consistent with our prediction, that the injection of SpMsx mRNA resulted in premature expression of SpMsx in preblastula stage embryos. Also, assuming a uniform distribution of the injected transcripts, SpMsx mRNA injection caused ectopic expression and overexpression of SpMsx in postblastula embryos. Furthermore, since the endogenous SpMsx gene is expressed in a subset of embryonic cells from the late blastula stage onward (summarized in Fig. 2B ), the measured amount of injected SpMsx transcripts represents an upper limit of SpMsx overexpression in postblastula embryos. A caveat is that we have not measured the level of endogenous SpMsx transcripts in SpMsx-injected embryos; thus, it is possible a feedback mechanism, positive or negative, results in a higher or lower number of transcripts than predicted by summing the endogenous and injected SpMsx transcripts.
We examined Msx2-injected, SpMsx-injected, and control embryos under DIC optics at various times after injection in order to look for gross effects of Msx overexpression on development ( Figs. 3 and 4 ; Table 1 ). At the same time, we stained embryos with antibodies against territory-specific marker proteins to evaluate more specifically the consequences of Msx2 overexpression on cell type specification (Fig. 5) . These proteins were SpecI for aboral ectoderm (Tomlinson and Klein, 1990) , Ecto V for oral ectoderm (Coffman and McClay, 1990) , and Endo1, which marks the posterior two-thirds of the gut (Wessel and McClay, 1987) .
The phenotypes resulting from injection of Msx2 and SpMsx were indistinguishable. Msx (SpMsx or Msx2)injected embryos developed normally through the morula and early blastula stages, but began to exhibit developmental defects at the mesenchyme blastula stage in the patterning of the PMCs (Fig. 3) . In normal development and in control embryos, PMCs become arranged in a subequatorial circular array (Figs. 3A and 3B). PMCs in injected embryos were less organized ( Figs. 3C-3H ). In some embryos the arrays were generally circular, although the arrangements of the PMCs were less precise than those in controls (Figs. 3C-3F). In other embryos, the PMCs appeared clumped (Figs. 3G and 3H ). The number of PMCs was unaltered.
In later stage Msx-injected embryos, additional defects were evident, particularly in endodermally derived and mesenchymal tissues (Fig. 4) . Approximately 50% of Msxinjected embryos had abnormalities in the development of the archenteron. These defects fell into three general categories, defined by (i) the complete absence of the archenteron (Figs. 4G and 4H), (ii) a truncated archenteron (Fig.  4E) , and (iii) an abnormally thin archenteron that lacked demarcations between the foregut, midgut, and hindgut (Fig. 5C ). The Endo I antibody did not stain embryos that lacked an archenteron, confirming the absence of gut tissue ( Fig. 5E and 5F ). Such embryos had not simply ceased to Defects in spiculogenesis were frequent and morphologically striking (Fig. 4) . In a majority of embryos, supernumerary spicules were evident, typically a total of five or six per embryo (e.g., Figs. 4F and 4I-4K) . These spicules were usually triradiate. However, both their location and morphology were abnormal. Spicule rudiments were often distributed radially around the vegetal hemisphere rather than ventrolaterally (not shown). By 72 h, spicules were abnor-mally shaped, exhibiting a range of morphologies from single to highly branched rods. In addition, a range of spicule sizes was evident, from a few cell diameters to approximately full length (Fig. 4I) . In normal spiculogenesis, the growth of various branches of the bilateral spicule rudiments is tightly regulated, and the overall size of the spicule is scaled to embryonic growth (Ettensohn and Malinda, 1993) . In Msx-injected embryos, spicule growth 
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Disruption of Primary Mesenchyme Cell Patterning was deranged and, because of the heterogeneity in spicule sizes, there was no scaling of spicule size to embryo size. Finally, these defects in spiculogenesis also occurred in embryos in which archenteron development was morphologically normal (not shown), demonstrating that there was not a necessary link between the abnormalities in archenteron development and defects in spiculogenesis.
The organization of the secondary mesenchyme was abnormal in Msx-injected embryos (Fig. 4) . Among the cell types derived from the secondary mesenchyme are the pigment cells. An initial set of progenitors of pigment cells ingress into the blastocoel at the mesenchyme blastula stage and then disperse into the aboral ectoderm where they express echinochrome pigment. In Msx-injected embryos, pigment cells were often concentrated in patches (e.g., Figs. 4G, 4H, and 4K). As with the PMC patterning defect, the abnormal distribution of pigment cells did not seem to be a direct consequence of an archenteron defect, since the distribution of pigment cells was also abnormal in embryos in which the archenteron was morphologically normal (not shown).
Approximately 85% of Msx-injected embryos exhibited distinct oral and aboral ectoderm territories. This was evident from the characteristic staining of the dense and cuboidal oral ectoderm cells with Hoechst 33342 (data not shown) and was confirmed by staining with the oral ectoderm marker, EctoV (Figs. 5G-5J) , and the aboral ectoderm marker, SpecI (Fig. 5K-5N) . In 72-h Msx-injected embryos, the distributions of Spec I and Ecto V were complementary in different regions of the ectoderm, as is typical of undisturbed embryos (compare Figs. 5J and 5N) . These patterns were thus consistent with the presence of distinct oral and aboral ectoderm territories. Approximately 10% of Msxinjected embryos that possessed both oral and aboral ectoderm as judged by marker analysis lacked a stomadeum. This demonstrated that despite regionalized Ecto V expression and the development of typical epithelial changes, oral ectoderm development was not always normal.
Transplantation of Micromeres Reveals That the Msx-Induced Defect in Primary Mesenchyme Patterning Is Conditional on the Prospective Ectoderm
The effects of SpMsx overexpression on the organization of the PMC ring, together with effects on spicule number and shape, suggest a defect in the interaction between the PMCs and the blastoderm. It is well established that signals from the prospective ectoderm control the location of the PMCs within the blastocoel, and that ectodermal signals also influence subsequent spicule morphogenesis (Armstrong et al., 1993; Ettensohn et al., 1997) . The endogenous SpMsx gene is expressed broadly in the prospective ectoderm of the midblastula-stage embryo; subsequently its expression becomes localized to the oral ectoderm and the vegetal plate (Dobias et al., 1997) . These data appear to rule out a simple model in which the localized expression of SpMsx in a subequatorial band in the ectoderm has a role in PMC guidance. Nevertheless, the possibility remains that SpMsx may function in a combinatorial manner with other genes to direct PMC guidance.
To determine whether SpMsx expression in the prospective ectoderm can influence PMC pattern, we designed a test for whether primary mesenchyme patterning is cellautonomous. Our approach was to create chimeric embryos that contained micromeres from injected embryos and mesomeres ϩ macromeres from noninjected embryos. The reciprocal combination of noninjected micromeres with mesomeres ϩ macromeres derived from injected embryos was also made (Fig. 6A) . In some experiments, micromeres were labeled with the fluorescent dye, RITC, prior to transplantation. This allowed us to verify that the transplant was successful and also provided a means of examining the patterning of the micromere progeny after they ingressed into the blastocoel.
Examples of RITC-labeled blastulae are shown in Fig. 6B , and the morphological phenotypes of chimeric embryos at the pluteus stage are illustrated by the images in Fig. 6C . In control blastulae in which RITC-labeled micromeres came from an uninjected embryo and the blastoderm from an Msx2 frameshift-injected embryo, the RITC-labeled cells were located inside the blastocoel and were arrayed in a regular, circular pattern (Fig. 6B, top) . This labeling pattern is consistent with the behavior of the primary mesenchyme in undisturbed embryos. Such control-injected embryos formed normal plutei, demonstrating that the microinjection and recombination manipulations did not significantly disrupt development (not shown). Chimeric embryos containing noninjected micromeres and a blastoderm derived from Msx-injected mesomeres and macromeres had deranged PMCs within their blastocoels (Fig. 6B, bottom) . At the pluteus stage, such embryos exhibited supernumerary spicules with abnormal shapes (Fig. 6C, bottom) , similar to the defects observed in nonchimeric Msx-injected embryos ( Fig. 3) . Of 15 chimeric plutei evaluated, 9 displayed this phenotype (Table 2 ). The development of the archenteron and the distribution of the pigment cells were normal in all of these chimeras (data not shown). Thus, curiously, overexpression of SpMsx in both the micromere and the nonmicromere portions of the embryo apparently was required for the pigment cell and gut phenotypes. The majority of control chimeras (11/12), containing Msx2 frameshiftinjected blastoderm and noninjected micromeres, had no discernible phenotype (Table 2) . A single chimera had two normal spicules and one supernumerary spicule rudiment too small in size to determine if its shape was abnormal (Table 2; data not shown). This rather mild abnormality may have been caused by the physical disruption of the embryo or some low-level biological activity of the Msx2 frameshift mutant. None of the chimeras (0/14, Table 2) bearing SpMsx-injected micromeres and a noninjected blastoderm had discernible developmental abnormalities (Fig.  6C, bottom) ; vegetal plate development was normal, as was the development of the larval skeleton. Therefore, overex-pression of SpMsx in micromeres or the skeletogenic mesenchyme was not sufficient to cause vegetal plate defects or disrupt spiculogenesis.
In summary, our data show that the defect in SpMsxinjected embryos in the location of PMCs within the blastocoel as well as the defects in the subsequent initiation and morphogenesis of spicules is conditional: Misexpression/overexpression of SpMsx in the prospective ectoderm alters signaling events that regulate spiculogenesis.
DISCUSSION
We show that perturbation of SpMsx expression in sea urchin embryos by mRNA injection results in abnormalities in the development of the vegetal plate and in the patterning of the primary mesenchyme and larval skeleton. Moreover, we demonstrate by blastomere transplantation that the abnormalities in primary mesenchyme and spiculogenesis are dependent on an interaction with the prospective ectoderm. Overexpression of SpMsx is therefore sufficient to alter the ectodermal signaling processes that mediate the patterning of the primary mesenchyme and the morphogenesis of spicules (Armstrong et al., 1993; Ettensohn et al., 1997) .
The impetus to test the function of SpMsx in the sea urchin came from findings that aspects of organogenesis in vertebrates and insects are sensitive to Msx gene dosage, and that Msx genes function in BMP-mediated signaling (Liu et al., 1995; Vainio et al., 1993; Chen et al., 1996; Suzuki et al., 1997) . Expression of the sea urchin SpMsx gene, at first generalized, becomes progressively restricted to the vegetal plate and oral ectoderm territories in the blastula stage embryo. Subsequently, it is expressed in the archenteron and in subregions of the oral ectoderm, including the elongating larval arms. This pattern of expression led us to expect that SpMsx could function in the progressive specification of embryonic territories occurring prior to and during gastrulation. Measurements of the stability of injected SpMsx message showed that the Msx mRNA was most probably overexpressed at sites of its normal expression and was ectopically expressed in the aboral ectoderm and PMCs at least through the late gastrula stage.
Embryos injected with either the murine Msx2 mRNA or the sea urchin SpMsx had archenterons of reduced length, as well as defects in the patterning of the primary and secondary mesenchyme and in spiculogenesis. Control injections revealed that these phenotypes were a specific consequence of SpMsx mRNA and, furthermore, that they depended on the translation of this mRNA into protein. Moreover, these phenotypes coincided temporally with the normal expression of the SpMsx gene in showing clearly that overexpression of SpMsx does not have a general, nonspecific effect on embryogenesis. Both Ecto V and Spec I, markers of oral and aboral ectoderm territories respectively, were expressed in SpMsxinjected embryos. Hence, the segregation of oral and aboral ectoderm was not substantially affected by overexpression of SpMsx. However, the expression of the Endo I, which marks the posterior two-thirds of the archenteron, was often reduced or absent in Msx-injected embryos, reflecting an inhibition of archenteron development. It is not clear whether this inhibition results from interference in the specification of cells that compose the archenteron or in a mechanical aspect of gastrulation. However, if the defect were mechanical, we might expect endodermal markers to be expressed even in embryos in which gastrulation was inhibited, which was not the case. Thus it seems more likely that overexpression/misexpression of Msx interferes with the specification of the archenteron. We cannot be certain whether this defect is caused by ectopic expression of SpMsx versus overexpression of SpMsx at sites of its normal expression. However, the archenteron phenotype is consistent with overexpression of SpMsx in the vegetal plate and/or archenteron.
Micromere Transplantations and the Cell Autonomy of the Msx-Induced Defects in PMC Guidance and Spiculogenesis
Micromere transplantation experiments established that the defects in primary mesenchyme patterning and spiculogenesis were conditional on the prospective ectoderm. Although the injected SpMsx mRNA is likely translated in PMCs at least through gastrulation (Dobias et al., 1997) , this expression apparently is irrelevant to the observed phenotypes. PMCs are capable of forming spicules in isolation, and the shape of such spicules is, to some extent, dependent on a cell autonomous program (Okazaki, 1975 ). Yet the initial guidance of PMCs to sites on the subequatorial ectoderm, as well as the subsequent initiation and morphogenesis of the spicule, are heavily influenced by signals from the ectoderm (Ettensohn, 1990; Hardin et al., a Injections and micromere transplantations were carried out as described in the legend to Fig. 6 . Spicule morphology was evaluated by DIC microscopy at the 60-h prism stage.
b Defective spiculogenesis is defined as supernumerary spicules, abnormally shaped spicules, or both.
c These sets of numbers, 9/16 with defective spiculogenesis vs 0/14 with normal spicules, were evaluated with Fisher's exact test and found to be significantly different (P ϭ 0.0007). 1992; Armstrong et al., 1993; Ettensohn and Malinda, 1993; Guss and Ettensohn, 1997) . The PMC ring is located at the approximate boundary of SpMsx expression in the vegetal plate and the ectoderm in the late blastula stage embryo; thus it is possible that when SpMsx is ectopically expressed in the ectoderm, a positional cue is abrogated, and PMC guidance is disrupted.
At least one derivative of the secondary mesenchyme, the pigment cells, also exhibited a patterning defect. During normal development these cells ingress into the blastocoel and migrate throughout the ectoderm (Ettensohn, 1992) . As with the PMCs, there was apparently no significant change in the number of pigment cells. However, pigment cells were usually distributed abnormally in the embryo, often forming aggregates at the animal pole.
Curiously this pigment cell defect was not seen in chimeric embryos. Neither did chimeric embryos exhibit abnormalities in archenteron development. This result implies that either normal micromeres or normal vegetal plate cells are sufficient for gut and pigment cell development. Ransick et al. (1995) demonstrated that specification of prospective gut cells requires interaction at the 16-cell stage with adjacent micromeres. At face value, our data show that misexpression of Msx genes does not alter the inductive capacity of micromeres, since chimeras consisting of SpMsx-injected micromeres and normal mesomeres ϩ macromeres develop normally. Yet misexpression of SpMsx apparently does not alter the competence of prospective gut cells to respond to signals from the micromeres, since archentera in chimeras containing normal micromeres and SpMsx-injected mesomeres ϩ macromeres also develop normally. Although we have no ready explanation for this apparent paradox, one possibility is that misexpression of SpMsx affects both the inductive activity of micromeres and the competence of adjacent cells, and that a limited regulative mechanism is able to compensate for the defect in chimeric embryos, but is not sufficient to overcome the defect in whole injected embryos.
After the initial phase of spiculogenesis in which PMCs are guided to sites on the blastocoel wall, PMCs form ventrolateral clusters and initiate spicule rudiments. These rudiments grow in a complex and tightly regulated fashion in concert with the growing larval arms. This pattern is disrupted in several ways in SpMsx-injected embryos. First, the number of spicule rudiments is increased to an average of five or six per embryo, and such rudiments are arrayed in FIG. 6 -Continued a radial pattern. Second, the patterns of spicule growth are deranged both spatially, in that the shapes of the spicules are abnormal, and temporally, in that the growth rates of the various spicule rudiments are extremely heterogeneous.
Treatment of embryos with nickel chloride (a ventralizing agent) or introduction of a dominant negative form the EGF receptor can also cause supernumerary spicules, as can introduction of a serotonin receptor into embryos (Hardin et al., 1992; Armstrong et al., 1993; Tomlinson, 1997) . Thus it appears that the supernumerary spicule phenotype per se is a relatively nonspecific consequence of perturbations in signaling processes. For this reason we do not attach great significance to this phenotype as an indicator of the normal function of SpMsx. On the other hand, SpMsx is expressed at the tips of the growing larval arms in the ectoderm, a tissue that has been shown to provide a permissive signal for spicule elongation . This expression pattern, together with the well-documented role of Msx genes in epithelial-mesenchymal interactions in vertebrate organogenesis, suggests that SpMsx may have a role in this signaling process.
SpMsx Overexpression Phenotypes and Embryonic Signaling Pathways
In Xenopus, injection of either Xenopus Msx1 mRNA or murine Msx2 mRNA into single-cell zygotes results in embryos that lack eyes and anterior head structures, and are thus ventralized (Suzuki et al., 1997; S.-J. Gong, personal communication) . Intriguingly, overexpression of these genes also inhibits the morphogenetic movements associated with gastrulation (Suzuki et al., 1997) . Differences in mode of development between vertebrates and echinoderms make it difficult to compare the morphological defects seen in Msx-injected sea urchin embryos with those in Xenopus. On a molecular level, there is compelling evidence that in Xenopus such phenotypes involve the BMP pathway. These phenotypes are very similar to those caused by injection of BMP4 mRNA (Jones et al., 1992) , which acts during gastrulation to attenuate the dorsalizing influence of the organizer (Jones et al., 1996) . Moreover, Msx1 can rescue embryos injected with mRNA encoding a dominant negative BMP receptor (Suzuki et al., 1997) . A role for Msx genes as downstream effectors of BMP signaling is apparently conserved in divergent animal groups. Epistasis studies suggest that the msh gene of Drosophila is regulated by the BMP4 homologue, Dpp (D'Alessio and Frasch, 1996) . Also, Msx2 expression is activated as an immediate early response to BMP4 in murine embryonic cells (Vainio et al., 1993; E. Yi, S. Dobias, R. Maxson, and K. Lyons, unpublished observations) , and BMP4 signaling is disrupted in the developing teeth of Msx1-deficient mice (Chen et al., 1996) . There is relatively little information on BMP4-related genes
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in the sea urchin. One such gene has been described (Stenzel et al., 1994) ; however, it is rather divergent from vertebrate BMP4s and thus is probably not a BMP4 orthologue. A closer relative of BMP4 has been identified recently, but has not yet been studied in detail (L. M. Angerer, personal communication). Despite the lack of information on the relationship between the BMP pathway and Msx gene function in the sea urchin, the conserved role of Msx genes in BMP signaling makes such a relationship likely. To what extent the Msx overexpression/misexpression phenotypes result from perturbations of BMP signaling is an interesting and accessible question.
What downstream targets of Msx2 are involved in the non-cell-autonomous influence on spiculogenesis? Intriguingly, from work in vertebrate embryos, one likely target is syndecan I (Chen et al., 1996) , a membrane-spanning proteoglycan that can interact with FGF and wingless ligands and enhance their activity (Heslip et al., 1997) . Homologues of syndecan I have been identified in both protostomes and deuterostomes (Spring et al., 1994) and are thus almost certainly present in the sea urchin embryo. It will be interesting, in light of our data, to determine whether syndecan or related components of the extracellular matrix have roles in PMC patterning or spicule morphogenesis.
